0      0

Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis


‐ Oct 4, 2020 11:36am


Credits: None available.


Credits

Credits: None available.